These publications and articles are available for immediate purchase and download. Payment is accepted via VISA, Mastercard, and American Express.We offer special rates for startup companies; academic and tech transfer programs; clinical trial sites; and individual clinicians. Please contact us at:

NeuroPerspectiveborder.jpg NeuroPerspective

Our bimonthly journal covering the cutting-edge therapies being developed for disorders of the central nervous system, including Alzheimer's, Parkinson's, TBI, schizophrenia, and depression--and the companies pursuing them. It enjoys worldwide readership and kudoes for its 'no-holds-barred' evaluations. One year, eleven issue subscription cycle. Academic, startup, and individual rates available: email us at

NLcovernew.jpg NeuroLicensing 2014-15 $3,300.00

NeuroLicensing 2014-15 assesses current trends in deal parameters, and focuses on the major and midsize companies who are involved in CNS licensing. Opportunities and licensing agendas/performance are appraised. A practical and affordable resource for licensing efforts on both sides of the transaction, both potential licensors and licensees.

Single issues of NeuroPerspective and selected features from NeuroPerspective and our annual publications can be purchased 'a la carte.' Click on the desired category to see the choices that are currently available.